Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03288025 · ClinicalTrials.gov registry record · NA

Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)

A NA study of Insulin Resistance and Pulmonary Arterial Hypertension, sponsored by The Cleveland Clinic.

Active
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT03288025 is a NA study of Insulin Resistance and Pulmonary Arterial Hypertension that is active but no longer recruiting, run by The Cleveland Clinic. The registered enrollment target is 34 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03288025, a NA study of Insulin Resistance and Pulmonary Arterial Hypertension, is active but no longer recruiting, sponsored by The Cleveland Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the extent to which diet and exercise may improve PAH through the modulation of insulin sensitivity. The central hypothesis is that dysregulated glucose metabolism elicits a response in PAH patients that can be modified by exercise and diet, thereby leading to improvements in pulmonary vascular disease.

Interventions

  • BEHAVIORAL Nutrition and Exercise

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2017-09-27
Est. Completion 2026-06-30
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03288025

The ClinicalTrials.gov registry entry for NCT03288025 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (86% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Nutrition and Exercise is the first listed.

NCT03288025 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03288025 about?

NCT03288025 is a clinical study titled "Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)". The purpose of this study is to investigate the extent to which diet and exercise may improve PAH through the modulation of insulin sensitivity. The central hypothesis is that dysregulated glucose metabolism elicits a response in PAH patients that can be modified by exercise and diet, thereby leadin...

What is the current status of trial NCT03288025?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2017-09-27. Estimated completion is 2026-06-30.

What conditions does trial NCT03288025 study?

This clinical trial studies the following conditions: Insulin Resistance, Pulmonary Arterial Hypertension.

What interventions are being tested in trial NCT03288025?

The interventions under investigation include: Nutrition and Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03288025?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03288025 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insulin Resistance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.